European Dermal Filler Market size is estimated to reach USD 2 billion by 2028, according to a latest forecast report by Graphical Research.

The increasing focus and growing awareness regarding facial aesthetics in the European region is expected to spur the adoption of dermal fillers in the region. Facial aesthetics includes a variety of non-surgical procedures that reduces signs of ageing and rejuvenates the skin. They help to enhance the facial appearance and provides a smoother or fuller texture to it. Moreover, these products can also be used to treat acne scars, reduction of nasolabial folds, and correction of cheek. The switching consumer attitude towards beauty, wellness, and healthy ageing have elevated the acceptance of facial aesthetics, initiating demand from new patient segments, inclusive of millennials and men. Technological advances and widespread use of social media have increased awareness about diverse standards of beauty and aesthetic outcomes. For instance, in May 2018, injectable product profile by IBSA Italia had been rewarded with the best injectable product in the Aesthetic Industry Awards in Europe. According to the manufacturer, profile is the first BDDE-free stabilized injectable hyaluronic acid-based product that aims to improve tissue quality and treating laxity of skin.

The rise in the number of manufacturers that are highly investing in developing new and innovative technologies related to aesthetic products is further anticipated to grow the market demand. For instance, a Swedish company, Bohus Biotech, developed an advanced dermal filler formulation by utilizing the spherification technology, with smooth, spherical-shaped particles replacing the traditional ones. These latest product formulations are exceedingly long-lasting and stable, leading to lesser number of procedures.

Nevertheless, the high expenditure linked with dermal filler procedures and decreasing reimbursement for reconstructive surgeries is affecting the market’s revenue. Also, the adverse reactions including bruising, redness, and granulation of skin are responsible for impeding the market size.

The biodegradable segment accounted for 85% market share in 2021, attributed to factors such as larger availability of product offerings and broader aesthetic applications of biodegradable products. For example, in March 2022, an aesthetic company, Hallura Ltd., based out of Italy announced successful topline results during their multi-site European clinical trial for their next-generation hyaluronic acid dermal filler with their proprietary BiOLinkMatrix platform. Thus, ongoing developments in biodegradable product line will impel the industry growth potential.

The hyaluronic acid {HA} segment will expand at a CAGR of 9.5% through 2028. According to the International Society of Aesthetic Plastic Surgery (ISAPS), over three million hyaluronic acid dermal filler procedures are performed annually. Additionally, various forms of hyaluronic acid dermal fillers are available, that differ as per the degree of crosslinking and the concentration of hyaluronic acid.

Browse detailed statistical insights from the report, “Europe Dermal Fillers Market Forecast 2028 By Application (Facial Line Correction, Face Lift, Lip Enhancement), By Type (Biodegradable {Temporary Biodegradable, Semi-permanent Biodegradable}, Non-biodegradable), By Material Type (Hyaluronic Acid {HA}, Calcium Hydroxylapatite {CaHA}, Poly-L-lactic Acid, Polymethyl-Methacrylate Microspheres {PMMA}), By End-use (Dermatology Clinics, Hospitals), Research Report, Country Outlook (Germany, UK, France, Spain, Italy, Russia, The Netherlands, Turkey, Austria, Belgium), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @

https://www.graphicalresearch.com/industry-insights/1554/europe-dermal-filler-market

The facial line correction segment was valued at USD 500 million revenue in 2021, due to the growing preference for young physical appearance and the focus on addressing dynamic facial lines and volume loss.

The dermatology clinics segment will witness 7.4% CAGR till 2028, owing to the rising number of specialty dermatology clinics along with increasing procedural volume.

Germany dermal filler industry will surpass USD 250 million by 2028, credited to the escalating expenditure on research and development and rising preference among individuals for undergoing dermal filler procedures. For instance, as per the International Society of Plastic Surgery (ISAPS) global survey results 2020, about 284,407 hyaluronic acid procedures were carried out in Germany, that makes it one of the prominent countries in Europe with the highest number of cosmetic procedures.

The European dermal filler market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:

Europe Market, by Type

• Biodegradable
  • Temporary biodegradable
  • Semi-permanent biodegradable
• Non-biodegradable

Europe Market, by Material Type

• Hyaluronic acid {HA}
• Calcium hydroxylapatite {CaHA}
• Poly-l-lactic Acid
• Polymethyl-methacrylate microspheres {PMMA}
• Others

Europe Market, by Application

• Facial line correction
• Face lift
• Lip enhancement
• Others

Europe Market, by End-use

• Dermatology clinics
• Hospitals
• Others

The above information has been provided for the following countries:

• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • The Netherlands
  • Turkey
  • Austria
  • Belgium